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Abstract As diabetes takes on pandemic proportions, it is crucial for the orthopedic surgeon
to be aware of the issues involved in diabetic foot. Ulceration is related to neuropathy and
to arterial disease, a vital prognostic factor for healing; infection plays an aggravating role,
increasing the risk of amputation. At-risk feet need to be screened for. Ulcer classiﬁcation is
essential, to set treatment strategy and determine prognosis. Before any treatment is decided
on, neuropathy, vascular insufﬁciency and infection should individually be assessed by clinical
examination and appropriate additional work-up. Despite the International Consensus on the
Diabetic Foot recommendations, management of diabetic foot in Europe still varies greatly from
country to country, very few of which have established reference centers. Management of dia-
betic foot remains multidisciplinary; but it has been shown that the orthopedic surgeon should
play a central role, providing a biomechanical perspective so as to avoid complications recur-
rence. Strategy notably includes prevention of at-risk foot, revascularization surgery (which
should systematically precede orthopedic surgery in case of critical vascular insufﬁciency), and
treatment of ulcers, whether these latter are associated with osteitis or not. Indications for
‘‘minor’’ amputation should be adequate, and meticulously implemented. ‘‘Acute foot’’ is a
medical emergency, entailing massive empirically selected I.V. antibiotics to ‘‘cool’’ the lesion.
Prophylactic surgery to limit further risks of ulceration is to be indicated with caution and only
when clearly justiﬁed. France urgently requires accredited specialized multidisciplinary centers
to manage severe lesions: deep and infected ulceration, advanced arteriopathy, and Charcot
foot arthropathy.
. All© 2011 Elsevier Masson SAS Based on a lecture by J.-L. Besse at the 84th SOFCOT annual Conven
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Introduction
The incidence of diabetes, especially of type 2, is
increasing throughout the developed world; the associated
complications make this a real challenge for public health.
There are presently estimated to be more than 120 million
diabetics worldwide, expected to rise to 333 million by 2025.
As well as acute metabolic complications, diabetes induces
chronic complications related to vascular damage and sec-
ondary neuropathy, mainly affecting three locations: eyes,
kidneys and feet. Management of diabetic foot lesions has
long been neglected.
We will present the classiﬁcations of diabetic foot lesions
and the means of diagnosis, and attempt to answer the ques-
tions facing the orthopedic surgeon:
• how to organize patient management?
• what are the respective roles of orthopedic and vascular
surgery?
• how to treat perforating plantar ulcer, with and without
associated osteitis?
• is ‘‘acute foot’’ a surgical or a medical emergency?
• what is the place of the prophylactic surgery and the risks
of orthopedic surgery in diabetic patients?
The present article is not the place to go into the complex
issue of neuro-arthropathy, which requires management in
a specialized center.
General considerations
Epidemiology
Studies of diabetic foot and the results reported vary greatly
according to the population under study, the diagnostic cri-
teria applied and the degree of specialization of the centers
concerned.
Diabetic foot ulcer
Prevalence data are relatively plentiful, but range from 3 to
25% according to the study, country or even region [1—4]. It
is presently estimated that 15% of diabetic subjects present
ulcer at some point in their life [5].
Amputation
Diabetic foot lesions entail a 15- to 20-fold increase in ampu-
tation risk as compared to the general population [6]. Annual
incidence varies greatly according to country and region [7].
Some 50% of amputations are in diabetic patients, [8,9]
and it is estimated that 5—15% of diabetics will undergo
amputation at some point in their life. Age, sex (male),
low socioeconomic status and other diabetic complications
(notably renal insufﬁciency, and especially in case of dialy-
sis) speciﬁcally increase amputation risk.Lesion prognosis
Diabetic foot lesions have functional and psychological con-
sequences and severely impact quality of life [10]. Ulcers
show frequent recurrence, and reduce life expectancy.
Apelqvist et al. [11] demonstrated the negative prognostic
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mplications of amputation in diabetes: a second amputa-
ion is necessary within 5 years in 50% of cases, with 58%
urvivorship.
hysiopathology
iabetic ulcers show three main distinct but interact-
ng factors: neuropathy and arteriopathy are secondary
auses of diabetes, and infection is a decompensation
actor.
Neuropathic and arteriopathic complications are seldom
solated but rather associated to a varying degree and lead-
ng to neuro-ischemic foot vulnerable to ulcer.
eripheral neuropathy
he exact prevalence of neuropathy in diabetes is estimated
t 20 to 60% depending on the diagnostic procedure, and
ncreases with chronic hyperglycemia, duration of diabetes
nd patient age. Neuropathy is found in more than 90% of
ases of diabetic foot ulcer. It is bilateral, symmetrical and
istal, showing ascendant evolution.
ensory neuropathy. Sensory disorder predominates; signs
epend on the type of neural ﬁber involved. Large ﬁbers are
nvolved in tactile and deep sensitivity, and small ﬁbers in
ain and heat sensitivity. Trauma and friction lesions thus
ecome silent.
otor neuropathy. Motor neuropathy induces weakness
nd atrophy of the intrinsic muscles of the foot, leading to
law toe. Secondarily, it contributes to loss of joint mobility,
hich is also due to conjunctive tissue glycosylation inducing
brosis of the joint, soft tissue and skin.
egetative neuropathy. Vegetative neuropathy induces
kin dryness with crevasses and ﬁssures providing entry
oints for infection; it contributes to hyperkeratosis in reac-
ion to hyperpressure. It also opens arteriovenous shunts
nd induces deregulation of capillary ﬂow: the neuro-
athic foot is hot, with frequent edema and dilated dorsal
eins.
onsequences. Peripheral neuropathy is the main factor in
iabetes of atonic ulcer (Fig. 1) with highly hyperkeratotic
eripheral halo and neurogenic osteo-arthropathy (Charcot
oot).
rteriopathy
rteriopathy is usually associated to a varying degree with
europathy (neuro-ischemic foot), with a low rate of iso-
ated ischemic lesions (around 20%).
acroangiopathy. Macroangiopathy is not speciﬁc to dia-
etes, but shows speciﬁc characteristics. Atheromatous
esions develop earlier and more rapidly, classically show-
ng multi-segment and distal involvement. It mainly affects
he distal superﬁcial femoral, popliteal, tibial, peroneal and
edis arteries; aorto-iliac locations are rare.
icroangiopathy. Microcirculatory effects, characterized
y thickening of the capillary membrane, induce abnor-
al exchange and aggravate tissue ischemia. The role of
icroangiopathy remains controversial.
onsequences. Diabetic arteriopathy progressively induces
hronic ischemia, which is an aggravating factor in foot
esions. The foot is cold and the skin becomes thin and shiny.
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Ulcers of ischemic origin are often secondary to
light trauma. Unlike neuropathic ulcers, they show
n erythematous halo without hyperkeratosis. Associ-
ted heel sore, induced by decubitus, is a chronic
esion with poor prognosis. Decompensation of such
istal arteritis may lead to ischemia or gangrene in
ne or more toes by primitive acute distal thrombo-
is (Fig. 2). Infection is always an aggravating general
actor.
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Figure 2 Ischemic lesions. A. Ischemic ulcer. B. Ischemic ulchead. C. Extensive ulcer under mid-foot (Charcot foot).
iomechanics of ulceration
he association of diabetic neuropathy and plantar hyper-
ressure is the cause of most ulceration. Loss of pressure
nd pain sensitivity leads to repeated local hyperpressure
nd shear stress in the hyperkeratotic region, under which
ffusion develops and exteriorizes into an ulcer. Moreover,
ny mechanical, thermal or chemical wound may also
ead to ulceration, diagnosed late due to the absence of
ssociated pain.
er after revascularization. D. Heel sore. C. Toe necrosis.
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Table 1 Plantar hyperpressure and ulceration factors.
Plantar hyperpressure and ulceration factors
Intrinsic factors
Foot morphology (pe cavus, hallux valgus, claw toe, etc.)
Plantar hyperkeratosis
Limited joint mobility
Severe foot deformity (Charcot foot)
Extrinsic factors
Non-adapted footwear (too tight, projecting seams)
Foreign body (pebble, nail, etc.)
Behavioral factors
Barefoot walking
Lack of daily foot surveillance
Impossibility of self-care
Poor hygiene (non-treated hyperkeratosis)
Iatrogenic factors
Maladapted nail care
Badly performed amputation
Table 2 At-risk foot groups.
At-risk groups Criteria
Group 0 No neuropathy, orthopedic deformity,
vascular disorder, foot wounds or history
of wound/amputation
Group 1 Neuropathy
Group 2a Neuropathy associated with orthopedic
deformity, but adequate joint motion
Group 2b Neuropathy and orthopedic deformity
associated with joint stiffness
Group 3 Neuropathy associated with one of the
following:
Arteriopathy, Charcot foot type
deformity (acute or chronic), History of
wounds
a
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•
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EResection of 1 or more metatarsal heads
Escalating amputation
Plantar pressure threshold. Most ulcers occur on the small
toes or hallux, facing the metatarsal heads. In the litera-
ture, it is agreed that there is no predictive threshold for
ulceration. The threshold depends on a large number of fac-
tors and varies between subjects. The most recent studies
focus not only on contact time and degree of pressure, but
more particularly on the 3D direction and propagation of
pressure in soft tissue. Table 1 shows the factors of plantar
hyperpressure and ulceration.
At-risk feet
A classiﬁcation of at-risk feet is essential for drawing up
prevention strategies. The International Working Group on
the Diabetic Foot (IWGDF) published a 5-group classiﬁcation
according to complication rates (Table 2) [12]. A French mul-
ticenter survey performed on a single day for all diabetic
patients in or consulting in 16 diabetology centers classiﬁed
17.5% as at high risk (groups 2 and 3) [13]
Ulcer classiﬁcationA classiﬁcation of diabetic feet is essential for drawing up
diagnosis and treatment strategies and to aid prognosis. It
further facilitates therapeutic assessment and communica-
tion between the teams involved.
v
t
v
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Table 3 Wagner classiﬁcation grades.
Wagner grade 0 Wagner grade 1 Wagner grade 2 Wa
High-risk foot Very superﬁcial
non-infected ulcer
Very deep infected
ulcer, limited
cellulitis
Ve
ulc
te
boHistory of major or minor amputation.
Several classiﬁcations have been published internation-
lly:
Wagner’s classiﬁcation [14];
the Texas classiﬁcation, reported by Armstrong in 1996
[15];
Mike Edmonds’ classiﬁcation;
the PEDIS classiﬁcation [16].
We will describe just Wagner’s classiﬁcation, the most
idely used, and the PEDIS classiﬁcation, the most
ecent, based on an international consensus. None of the
lassiﬁcations, however, take account of neurogenic osteo-
rthropathic foot (Charcot foot).
Wagner (Table 3) classiﬁes lesions in six grades of
ncreasing severity, 0—5. Grades 1 to 3 are basically neuro-
athic ulcers of increasing severity according to depth and
nfection, while grades 4 and 5 are vascular lesions. The clas-
iﬁcation is simple, but fails to take account of the degree
f vascular insufﬁciency that may be associated with grades
—3.
The PEDIS classiﬁcation is based on ﬁve parameters (Per-
usion, Extent, Depth, Infection and Sensitivity) [17] that are
mportant in treating wounds in diabetic subjects (Table 4).
ach diabetic wound can be described by ﬁve elements, indi-
idualizing prognosis. The classiﬁcation is thus more precise
han Wagner’s. Most ulcers are induced by neuropathy, but
ascular status determines prognosis. Infection is an extra
everity factor for limb prognosis and patient survival.
gner grade 3 Wagner grade 4 Wagner grade 5
ry deep infected
er with
ndon/fascia and/or
ne involvement
Limited
gangrene
Extensive
gangrene
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Table 4 PEDIS classiﬁcation.
Perfusion
Grade P1 No symptoms, no signs of peripheral
arteriopathy
(ABI: 0.9-1.1 or TcPO2 > 60mmHg)
Grade P2 Symptoms or signs of peripheral
arteriopathy, no critical limb ischemia
Grade P3 Critical limb ischemia
(TcPO2 < 30mmHg or Systolic ankle
pressure < 50mmHg)
Extent
Wound size (cm2) after debridement
Depth
Grade D1 Superﬁcial dermal ulcer
Grade D2 Deep ulcer, penetrating below dermis to
subcutaneous structures, involving
fascias, muscles or tendons
Grade D3 All following layers, inc. bone and/or
joint
(bone contact or ulcer penetrating to
bone)
Infection
Grade I1 No symptom or sign of infection
Grade I2 Infection involving skin and
subcutaneous tissue
(at least 2 of the following: local edema
or induration, erythema> 0.5—2 cm, pain
on pressure, local heat, purulent
effusion)
Grade I3 Erythema> 2 cm plus one of the above
(edema, pain on pressure, heat,
effusion)
or deeper infection (abscess,
osteomyelitis, septic arthritis, fasciitis,
etc.)
Grade I4 Infection with systemic signs.
(at least 2 of the following:
temperature > 38◦ or < 36◦, heart
rate. < 90/min, resp. rate. > 20/min,
PaCO2 < 32mmHg, GB > 12000, 10%
non-differentiated leukocyte forms)
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Grade S1 No loss of protective sensation
Grade S2 Loss of protective sensation
iagnosis
efore making any treatment decision regarding a wound in
diabetic patient, any physician needs to diagnose neuropa-
hy. But assessment of vascular insufﬁciency and infection is
etermining for prognosis, and for classiﬁcation on the PEDIS
ystem.
Prior interview determines:
duration of diabetes, glycemic balance (glycemic
hemoglobin: Hb A1C > 7% indicates poorly balanced
diabetes);
associated renal and ocular complications;
history of ulcer or of minor amputation;
social context of care.
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europathy
europathy associated with diabetes is progressive but
ilent. It should therefore be systematically looked for as
art of any foot examination in diabetic patients. When diag-
osed, even without wound or history of wound, speciﬁc
reventive education is mandatory, as neuropathy is a fac-
or in foot ulcer. Almost all diabetic patients with ulcer show
ensory neuropathy; Charcot foot is another consequence of
europathy.
creening
wo simple tests should be known.
0 g 5.07 monoﬁlament. Semmens-Weinstein monoﬁla-
ents are a rapid means of exploring pressure sensitivity.
he 5.07 curved nylon monoﬁlament (equivalent to 10 g,
orresponding to the sensation level required to avoid foot
lceration) is applied perpendicularly on the skin. Several
lantar sites are explored, of which 3 must be sensitive: hal-
ux pulp, and 1st and 5th metatarsal heads. Each site should
e tested three times in succession including one sham appli-
ation in which the monoﬁlament is not applied. This is the
ost reliable screening method, and it is cheap and within
nyone’s capacity!
28Hz tuning fork. The tuning fork explores vibratory sen-
itivity on the dorsal side of the 1st metatarsal.
ther examinations
hermo-algesic sensitivity can be assessed on Neurotherm®
hot/cold test) and calibrated Neurotip test. Clinical neu-
ologic examination may if necessary be associated to
lectrophysiological examination.
ascular insufﬁciency
ascular involvement should be systematically investigated
s associated neuropathy generally masks the classical
ymptoms (notably, pain).
Clinical examination may be misleading. Pale cold skin,
he classic sign, is often not observed due to associated veg-
tative neuropathy. Due to mediacalcosis, dorsalis pedis and
osterior tibial pulse does not mean there are no microan-
iopathic lesions. Table 5 presents the various vascular tests
nd imaging modalities.
nfection
nfection is the aggravating factor in diabetic ulcer, and may
how rapid evolution, causing an emergency.
Clinical examination of the foot systematically looks for
ny entry point. Any general signs are noted: temperature,
nd heart and respiratory rate elevation. Biological exami-
ation analyzes diabetes balance, blood count, erythrocyte
edimentation rate and CRP assay.linical examination
eddening, tumefaction and erythema indicate soft-tissue
nﬂammation. Infection is often deeper than estimated.
‘‘sausage-like’’ edematous erythematous aspect in a
oe suggests osteoarthritis. Perforating ulcers should be
Diabetic foot: The orthopedic surgery angle 319
Table 5 Vascular tests and imaging.
Vascular tests Aim Interpretation
Ankle/arm index and TcPO2
Systolic ankle/arm
pressure index (AAI)
Demonstrate lower
limb arteriopathy and
estimate severity by
pocket Doppler
AAI: > 1. Inconclusive, related
to mediacalcosis (medial
calciﬁcation), fails to exclude
arterial insufﬁciency
AAI: 0.9—1.1. Normal
AAI: 0.5—0.9 (ankle
pressure > 50mmHg). Vascular
involvement. Patient
asymptomatic or with
claudication
AAI: < 0.5 (systolic ankle
pressure < 50mm Hg). Critical
ischemia.
TcP02 (transcutaneous
measurement of partial
oxygen pressure)
Assess cutaneous
oxygenation
TcPO2 > 60mm Hg. Normal
vascularization
TcPO2 30—60mmHg. Sign of
vascular involvement but no
critical ischemia
TcPO2 < 30mmHg. Critical
ischemia
Radiology Aim Pros Cons
Vascular imaging
Echodoppler Screen for diabetic
arteriopathy
Assesses permeability of distal
aorta, iliac femoro-popliteal and
infrapopliteal arteries
Identiﬁes and locates stenoses or
segment obliterations
Angio-MRI Diagnose lower-limb
arterial stenosis
No nephrotoixic contrast medium
injection (except Gadolinium)
Gadolinium: reports of
‘‘nephrogenic systemic
ﬁbrosis’’ following
administration of gadolinium
chelates, especially
gadodiamide, in patients with
severe renal insufﬁciency
Arteriography Diagnose lower-limb
arterial stenosis
(reference examination)
Allows subsequent endovascular
revascularization
Excellent image quality
st re
Invasive
Costly
Risk of complications, notably
•La
examined using a stylus or sterile forceps: ‘‘rough’’ bone
contact indicates osteitis or osteoarthritis unless proved oth-
erwise (Fig. 3).
Bacteriology
In the absence of clinical or general signs of infection, it is
not recommended to take bacteriological samples, culture
of which would show only colonization ﬂora.
In case of superﬁcial or deep infection, on the other hand,
bacteriology is essential.
It may comprise:
•
•sort imaging renal insufﬁciency induced by
contrast medium
Swabbing. This requires very strict conditions, to avoid
contamination: debridement of necrotic tissue, no anti-
septics, washing of the foot in water then of the wound
in physiological saline. This should be repeated several
times in consultation. To be contributive, several concor-
dant results are necessary. Deep ulcer sometimes requires
deep sampling, or bone sampling by curette.
Needle puncture of effusion, either percutaneous or
under ultrasound control.
The gold standard remains surgical bone and deep soft-
tissue biopsy.
320 J.-L. Besse et al.
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[igure 3 Infections. A. Erythema. B. Limited cellulitis of 5t
uncture.
Superﬁcial infection is usually mono-microbial (Staphy-
ococcus aureus, Streptococcus, etc.) and deep infection
ulti-microbial (Gram+, Gram− and anaerobic). Bacteri-
logy samples taken in consultation, even under strict
onditions, lack speciﬁcity, which is to be borne in mind in
stablishing the appropriate antibiotherapy [18].
steo-articular imaging
nfection can be assessed on standard X-ray, CT, MRI and
sotopic examination.
tandard X-ray. Signs of osteitis occur later than onset of
nfection; moreover, osteitic and neuro-arthropathic lesions
Charcot foot) can be hard to distinguish. A metaphyseal-
iaphyseal lytic aspect, however, is relatively characteristic
f osteitis, especially in the forefoot. We recommend sys-
ematic standard X-ray in PPU and suspected osteitis,
ith comparative assessment at 1 and 2weeks: in case
f osteitis, osteolysis, which was initially absent, will be
isible at 2weeks. This is a simple and essential com-
arative examination to assess osteo-articular infection
19].
T. CT usefully conﬁrms osteolysis in case of ambiguous
-ray.
adolinium-enhanced MRI. The literature [20] recognizes
adolinium-enhanced MRI as a good means of diagnosing
steitis. It differentiates osteoarthritic from neurogenic
steo-arthropathic lesions [21]. We reserve it for ‘‘acute
oot’’ with cellulitis. It is the examination of choice for
iagnosing deep soft-tissue effusion and extension to tendon
heaths, and serves to guide surgical drainage.
ltrasound. Ultrasound diagnoses effusion and abscess,
nd may guide puncture for bacteriology.
sotopic examinations. In case of uncertain diagnosis on
tandard X-ray and/or CT, we consider bone technetium
cintigraphy using labelled polynuclears to be the exami-
ation of choice for diagnosis of osteitis.
f
s
r
ae. C. Bone contact in ulcer. D. Bacteriology swab. E. Needle
rganization of management
nternational Consensus on the Diabetic Foot
ccording to the International Consensus on the Diabetic
oot, published by the IWGDF in 1999, prevention and treat-
ent of complications in diabetic foot should be organized
t three levels.
evel 1: GPs, nurses and podiatrists
atient awareness of foot problems and prevention, and of
arly diagnosis of ulceration.
evel 2: Diabetologists, diabetology nurses, surgeons
general and/or vascular and/or orthopedic)
anagement of basic preventive and curative care:
evel 3: Reference centers
eference centers should be capable of close multidis-
iplinary teamwork between diabetologist, orthopedic
urgeon and vascular surgeon, to manage the most difﬁcult
ases: deep infected ulcer, severe arteriopathy, Charcot
oot.
Reality is often far from such an ideal. Several studies
ound that less than 50% of diabetic subjects had annual
oot examination, whether by their GP or their diabetologist
22,23], and that home check-ups remained too few, ranging
rom 20 to 70%.
In 2008, a prospective European study [24] in 14 centers
till found treatments that failed to respect international
ecommendations, with wide variations between countries
nd centers.
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Treatment
Treatment of diabetic foot is usually multidisciplinary,
involving different specialties. Vascular and infectious ulcer
assessment allows adapted treatment. Basic principles need
to be respected: non-weight-bearing, debridement, control
of infection, revascularization if necessary, and adapted
wound care. Ulcer classiﬁcation enables the various physi-
cians to use the same tools and particularly to compare
results across treatment protocols.
Prevention in at-risk feet
Only preventive measures can limit the incidence of ulcer
and amputation and the costs incurred by diabetic foot.
They are based on general (optimal glycemic balance, pre-
vention of associated cardiovascular risk, smoking cessation,
etc.) and speciﬁc measures (podiatry, orthoses, adapted
footwear and patient education). Primary prevention begins
with screening for risk of ulcer; this involves systematic, at
least once-yearly foot examination, notably for neuropathy
and foot deformity, and also education in the risk of spe-
ciﬁc foot complications. Secondary prevention in patients
with grade 1—3 risk feet associates education, systematic
screening and multidisciplinary follow-up.
Education
Education concerns both the patient and the care workers.
The patient. Education is individual and adapted to the
patient’s complications and sociocultural level. It comprises
several axes: daily self-examination of the foot, podiatry,
permanent use of adapted footwear with prohibition of
barefoot walking, use of natural ﬁber seamless socks and
stockings, avoidance of aggressive substances and burns,
not raising the feet at rest, and early recognition of lesions
requiring immediate consultation. The patient’s family is to
be involved in education and prevention.
Health-care workers. All of the health-care professionals
must co-ordinate their actions to avoid contradiction. They
should therefore be brought together in a multidisciplinary
team, and any center managing diabetic foot should have a
nurse specialized in diabetology and education, as well as a
podiatrist.
Footwear
Various devices are available to prevent onset or recurrence
of foot ulcers.
Plantar orthoses. Insoles have a preventive and sometimes
curative function. Basically, they distribute pressure, more
rarely with corrective elements.
Orthoplasties.. Orthoplasties are little molded silicone
devices that protect areas of conﬂict with the shoe (notably
at the toes).
Shoes. Shoes are essential to prevention. They may be
adapted mass-produced models, semi-therapeutic or made-
to-measure orthopedic shoes.
b
a
C
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pFigure 4 Role of vascular surgery.
ole of vascular surgery
efore treating any diabetic ulcer, it is essential to correct
ascular insufﬁciency. Amputation or orthopedic surgery
hould never be indicated before precise assessment of
ower limb vascular status. Anesthesia should bear in mind
hat coronary involvement is often silent in diabetes. Critical
ower limb ischemia in diabetes is seen clinically as an ulcer
ith necrosis, pain in decubitus or claudication that is inter-
ittent but more frequent than in non-diabetics due to the
ssociated neuropathy. Revascularization, when feasible, is
ssential to ulcer healing, enabling tissue oxygenation and
etter diffusion of antibiotics.
In practice, vascular assessment in case of ulcer com-
rises Doppler and if possible TcPO2 measurement: if this is
30mm Hg, vascular advice is mandatory (P3 on the PEDIS
lassiﬁcation). Depending on the complementary examina-
ion results, revascularization, using whatever technique,
ay be envisaged (Fig. 4).
The main revascularization procedures are: distal
ridge, endovascular techniques, stenting and percuta-
eous intentional extra-luminal revascularization. Lumbar
ympathectomy is not indicated in lower limb diabetic arte-
iopathy. Hyperbaric oxygen therapy may be used in case of
lcer with associated non-revascularizable severe arthritis.
oot ulcers without osteitis
hese lesions are usually managed non-surgically, on an
mbulatory basis in medical (diabetic podiatry) consultation
D1 and D2 on the PEDIS classiﬁcation). Treatment comprises
on-weight-bearing for the affected foot and wound cleans-
ng and dressing.
on-weight-bearing
his is the essential and fundamental element of treatment,
ithout which any hope of healing is chimerical. The two
asic principles of local ofﬂoading and wound debridement
re mandatory.
omplete bed-rest. Complete bed-rest is the ideal guar-
ntee of non-weight-bearing, but is unrealistic over a long
eriod. It is prescribed during the acute phase of the wound,
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ssociated to use of a wheelchair, or crutches for hygiene
are. It is also often an opportunity to take stock of the
atient’s situation.
ostoperative shoes. We mainly prescribe BaroukTM fore-
oot or SanitalTM hindfoot pressure-relief shoes. Being
emovable to allow for dressings and avoid the hyperpres-
ure points induced by cast immobilization, they entail a
roblem of strict compliance with non-weight-bearing.
fﬂoading casts.
The Total Contact Cast (TTC). TTC is the reference
reatment for ulcer and acute Charcot foot. The aim is to
chieve homogeneous pressure distribution in the plantar
rch throughout the step: 30 to 50% of pressure is absorbed
y the cast [25]. Its non-removable 24/24 concept is funda-
ental to success, enabling healing in 70 to 85% of cases.
owever, it requires great experience in production (Fig. 5).
fﬁcacy in terms of plantar pressure relief and healing is bet-
er in the fore- and mid-foot than in the hindfoot [26,27].
t should be changed weekly. The associated complications
ate varies from 5 to 30% [28]: friction lesions liable to
nduce new infected wounds, venous thrombosis, etc.
Fenestrated [29] and/or removable casts [30]. These
nable the wound to be monitored, and reduce the risk
f complications. However, while the window around the
lcer makes dressing easier, it can also induce surrounding
yperpressure.
Commercial removable pneumatic casts (AircastTM).
hey are an alternative when qualiﬁed cast-makers are not
vailable. They are a little less effective in ofﬂoading [31];
emovability can be countered by using resin tape [32].
fﬁcacy. Due to compliance issues, non-removable casts
ive shorter healing times than postoperative shoes and
neumatic casts [33]. The Total Contact Cast is the gold
tandard according to the IWGDF consensus, but is in fact
nly used by a few specialized teams [34].
ound cleansing
ound care begins with disinfection of the wound itself
nd the surrounding area: careful washing with water, then
pplication of antiseptics; polyiodine solutions are more
ffective than chlorhexidine and do not affect healing, while
reventing the emergence of resistant bacteria (MRSA) [35].
ocal antibiotics are not indicated, for the same reasons.
Any ulcer requires limited debridement in consultation,
sing a lancet knife to remove surrounding callosities. The
ound can then be contoured by curette to remove any yel-
owish necrotic residue or ﬁbrin. This mechanical cleansing
s essential, in order to promote healing. Some ulcers may
equire removal of necrotic structures and surgical cleans-
ng.
ressing
n the absence of any rigorous comparative studies, there
s no consensus as to the type of dressing to use in dia-
etic foot. Dressings should, however, have a certain number
f properties: maintaining a humid microclimate, absorb-
ng exsudate, protecting from bacterial contamination, and
eing replaceable without local trauma. Choice depends on
he type and location of the wound.
Biotechnological approaches have been studied in dia-
etic foot: growth factors (mixtures of PDWHF, PGDF,
m
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tc.), platelet gels, live skin substitutes (epidermal, der-
al or composite). Physical approaches such as VAC (Vacuum
ssisted Closure) and hyperbaric oxygen therapy are some-
imes recommended to accelerate neovascularization and
ealing.
ole of surgery
n PEDIS D1 and D2 lesions, orthopedic surgery may be indi-
ated to promote healing or avoid recurrence in resistant
orefoot ulcer. There is thus the possibility of percutaneous
engthening of the Achilles tendon, or sectioning the gas-
rocnemial aponeurotic lamina in case of ankle stiffness
ithout dorsiﬂexion or even with slight equinus [36,37].
ikewise, metatarsal elevation osteotomy in case of hyper-
ressure caused by stasis disorder, or percutaneous distal
steotomy of the lateral metatarsals are possible, to relieve
yperpressure on a PPU. The aim of such surgery is to reduce
echanical stress in the forefoot.
In case of signiﬁcant loss of substance secondary to sur-
ical cleansing, plastic surgery may make a contribution if
ascular status is satisfactory (P1, P2 on the PEDIS clas-
iﬁcation) and factors of hyperpressure can be modiﬁed.
rafting may use a small bilobed rotation ﬂap after plantar
lcer resection, or sural (or other) local ﬂaps for heel-sore
equelae.
oot ulcers with osteitis
he association of osteitis and ulcer (PEDIS D3) requires pro-
onged antibiotherapy, generally beginning with a parenteral
ourse, and managed in coordination with the infectologists.
here is, however, no international consensus on infectious
esion management in diabetes [38]. Multidisciplinary man-
gement may call on surgeons for revascularization, bone
iopsy, bone curettage or minor amputation. It is to be
orne in mind that residual osteitis or secondary induction
f hyperpressure or of deformity may cause footwear issues
nd entail a risk of recurrence. Any surgery in case of osteitis
hould leave a foot that is functional and balanced in terms
f tendons. Vascular status and the orthotic options need to
e reconsidered after each operation.
mputation
he aim in amputation is to obtain a stump that can eas-
ly be ﬁtted, to conserve as great a length as possible while
nabling direct closure, and to conserve the patient’s auton-
my. Whenever possible, minor amputation fully conserving
imb length is to be systematically preferred to full-leg or
bove-knee amputation.
orefoot
e try to think in terms of function and biomechanics, rather
han purely of ulcer and osteitis, in deciding on the level
nd extent of any amputation [5,18,39]. It is important to
void progressively slicing away at the toes, which is harm-
ul both generally and psychologically: leaving two or three
iddle toes on a forefoot is a mechanical absurdity which
an only lead to rapid recurrence of ulceration (Fig. 6). In
he forefoot, in case of osteitis facing an ulcer, we opt for
urative orthopedic surgery, rather than prolonged exclu-
ively medical management guided by bone biopsy or even
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with
rcem
sFigure 5 Total Contact Cast. A and B. Protection of forefoot
and then wadding. D. Successive layers of plaster. E. Resin reinfo
of ulcer managed with TCC. H. Result at 6weeks.
curettage or minimal bone surgery [40] associated to pro-
longed antibiotherapy. With this ‘‘carcinologic’’ attitude of
minor orthopedic amputation (removing all infected tissue,
extending into the healthy bone) associated to primary clo-
sure and a postoperative antibiotic spectrum of less than
1-month, we have obtained 91% recurrence-free recovery
from osteitis, with a mean cicatrization time of 33 days [19].
P
e
h
5
eVelband® separating toes. C. Leg and foot covered by stocking
ent. F. Device with absorbent sole to allow walking. G. Example
According to location, we recommend the following bone
urgery procedures.
artial toe amputation. We avoid complete amputation,
specially of the 2nd toe, that would induce or increase
allux valgus. Likewise, 5th toe amputation may induce
th metatarsal head conﬂict and hyperpressure, as the lat-
ral side of the foot exerts a braking effect and the hallux
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sigure 6 Escalating amputations. A. Recurrence of ulcer with
nd 3rd toe conserved).
propulsion effect during gait. The objective is inter-
halangeal amputation with maximal conservation of the
roximal phalanx. A ‘‘shark’s mouth’’ incision is preferable,
onserving a more richly vascularized pulpar ﬂap.
ransmetatarsal ray amputation. We use transmetatarsal
ay amputation as an alternative to complete toe ampu-
ation, especially for the 2nd and 5th rays, with very
atisfactory results, avoiding hyperpressure in the remaining
ead, which would induce recurrence. Resection of a single
ateral ray has little impact on foot width, inducing very lit-
le pathologic overload in the adjacent rays (Fig. 7). The 5th
etatarsal should be osteotomized obliquely. However, we
o our best to avoid hallux or even 1st ray amputation, which
ould impact the lateral rays, inducing claw toe. In case of
allux lesion, we try to cure the osteitis by antibiotherapy,
ossibly associated to Keller arthroplastic resection. When
allux amputation is necessary, 1st metatarsal length should
e conserved as much as possible, so as to allow for possible
econdary transmetatarsal amputation.
solated metatarsal head amputation. We occasionally
erform isolated amputation of the metatarsal heads.
etatarsal head osteitis is often associated with ﬁxed claw
oe or vascular involvement in the toe, which is rather an
ndication for ray amputation. Moreover, isolated amputa-
ion of the metatarsal head is seldom satisfactory in terms
f infection control. On the other hand, in certain cases and
otably in surgical revision, alignment resection of all the
ateral metatarsal heads may be indicated, as in rheumatoid
olyarthritis.
ransmetatarsal amputation. Transmetatarsal amputation
ay be considered when it is not possible to conserve at
east three metatarsals on the lateral rays or four if the 1st
ay is resected. It is a very good procedure if performed elec-
ively, with primary closure allowing adequate soft-tissue
overage of the amputation stump. It is associated to plantar
xtensor tenoplasty to avoid secondary equinus and con-
erve active motion in dorsiﬂexion [41]. It is indicated when
c
t
i
r
asteitis (1st and 2nd toe conserved). B. Recurrence of ulcer (2nd
steitis lesions involve several rays, and especially when
nly two or three toes remain following iterative surgery
or recurrent ulcer or necrosis (Fig. 3). The level of ampu-
ation depends on the septic lesions: skin incision is convex
n the dorsal side, and the plantar ﬂap needs to cover the
ntire resection area, as it constitutes a focus of pressure
uring walking and shoe-wearing (Fig. 8).
Baumgardner’s variant procedure [42] consists in trans-
etatarsal amputation of one or more metatarsals,
onserving the toes.
id- and hind-foot
urgical treatment is more difﬁcult in the mid- and hind-
oot, as amputation beyond the tarso-metatarsal Lisfranc
oint line is less functionally satisfactory. In such locations,
herefore, management of diabetic osteitis is medicosur-
ical, with heavy antibiotherapy prolonged for several
onths. Surgery is complementary.
isfranc amputation. Lisfranc amputation involves consid-
rable loss of foot length, and creates tendon imbalance. It
s important to conserve the peroneal tendon insertion (or to
einsert into the cuboid) and anterior tibial tendon. The 2nd
etatarsal base, enclosed between the cuneiforms, should
e conserved so as to conserve the proximal arc. At end of
urgery, or secondarily in case of sepsis, posterior tendon
engthening is often required, in order to avoid equinus.
hopart’s midtarsal amputation. Classically Chopart’s
mputation results in secondary varus and equinus decom-
ensation. When there is no relative ischemia, anterior
ibial and peroneus brevis tenoplasty (by anchors or tran-
osseous reinsertion between the talar head and greater
alcaneal apophysis) is associated, with 2—3 cm resection of
he Achilles tendon [43], to avoid secondary equinus. Tendon
mbalance creates orthotic problems and cutaneous recur-
ence around the anterior amputation stump, preventing
ctive dorsiﬂexion (Fig. 9).
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(Figure 7 Ray amputations. A. Aspect, cosmetic 2nd ray amp
osteitis. D. Limited cellulitis of 5th toe. E. 5th ray amputation.
Partial or total calcanectomy. In case of loss of talar sub-
stance associated with calcaneal osteitis, partial or often
total calcaneal resection [44], by posterior incision, is a sal-
vage strategy. The soft-tissue gain following bone resection
often allows primary closure. A talar compensation orthosis
is then required.
Other amputations. Syme ankle disarticulation is complex,
with a risk of instability of the plantar soft tissues of the
distal tibio-ﬁbular stump. Severe infection or ischemia con-
traindicate this procedure. Pirogoff-Boyd amputation has
the advantage of conserving sufﬁcient limb length to avoid
the need for orthoses in everyday life.‘‘Acute’’ foot
‘‘Acute foot’’ covers ulcer associated with signs of severe
locoregional (PEDIS I3) and/or general infection (PEDIS I4).
l
(
l
4ion. B. X-ray after 2nd ray amputation. C. Ulcer with 5th toe
e usually avoid any emergency surgery, which leads to
xtensive debridement or amputation without skin closure.
irected cicatrization then often takes several weeks, with
ragile stumps and risk of recurrence of ulcer.
Our experience of teamwork between endocrinologists
nd orthopedic surgeons enables us, almost systemati-
ally, including for patients presenting with septicemia
nd/or diabetic decompensation, to ‘‘cool’’ acute-foot
esions using parenteral empiric broad-spectrum bi-
r tri-therapy [18,19,45]. We can recommend [46]:
amoxicilline—clavulanic acid)± (aminoglycosides [gentam-
cin or netilmicin] or quinolones) in case of cellulitis;
piperacillin—tazobactam) + (teicoplanin [or vancomycin or
inezolid]) + (quinolones) when the limb is threatened; and
imipenem [or ertapenem]) + (teicoplanin or vancomycin or
inezolid) + (aminoglycosides) in case of septic shock. After
8—72 hours of this ‘‘drug wager’’, locoregional and general
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Figure 8 Transmetatarsal amputation. A: Case 1—M3 head osteitis with ulcer. B. Transmetatarsal amputation (post-op aspect
a Hg)
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pnd control X-ray). C. Case 2—Hallux gangrene (TcPO2 at 25mm
ost-op aspect and X-ray. F. Secondary plantar orthosis compen
nfection evolution is reassessed, and indications for abscess
ebridement or iterative amputation are considered. Emer-
ency gadolinium-enhanced MRI is very useful in acute foot
o diagnose deep soft-tissue effusion and extension into ten-
on sheaths so as to guide surgical drainage.
Such heavy antibiotherapy protocols, drawn up in coor-
ination with infectologists, transform acute into subacute
r chronic lesions so as to enable scheduled surgery within
or 2weeks of treatment initiation. Meanwhile, assessment
s
s
w
s
c. D. Amputation with primary closure. E. Case 3—amputation:
g forefoot.
s completed, notably with advanced vascular evaluation
y TcPO2 and arterial Doppler and, depending on the
esults, arteriography and/or angio-MRI. A revascularization
rocedure ahead of possible orthopedic surgery may be con-
idered. In case of associated osteitis, scheduled orthopedic
urgery observes the same principles as in case of ulcer, but
ith transmetatarsal amputation, as lesions are often more
evere and skin necrosis may be associated with the initial
ellulitis.
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fFigure 9 Chopart’s amputation. A: Lesion secondary (D8) to ‘
stage of amputation: 2 cm resection of Achilles’ tendon. C. Am
tendons. E. Immediate postoperative aspect. F. Result at 1 mon
Preventive surgery
Diabetes is a risk factor in orthopedic surgery. Diabetic
neuropathy and/or arteriopathy were classically contraindi-
cations for foot surgery, due to the risk of infection,
cicatrization disorder and necrosis. In diabetic neuropa-
thy, however, static disorder and deformity, especially in
the forefoot (hallux valgus, claw toe, etc.), increase the
risk of ulcers which could lead to secondary amputation.
‘‘Preventive’’ foot surgery is therefore an issue in dia-
betes.
E
‘
S
iecessary’’ emergency 2nd toe amputation in acute foot. B. 1st
tion ﬂaps. D. Tenoplasty of anterior tibial and peroneus brevis
In practice, two situations are to be distinguished: static
isorder of the foot in a diabetic patient without signs of
‘at-risk foot’’, and preventive procedures in at-risk diabetic
eet with or without history of ulcer.lective surgery in diabetes without signs of
‘at-risk’’ foot
urgery for foot stasis disorder requires complete prelim-
nary assessment to rule out neuropathy and arteriopathy.
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n the absence of sensorimotor lower limb neuropathy and
iven a relatively satisfactory vascular status, the risks
ntailed by foot surgery are not much greater than with non-
iabetic patients. The techniques are those classically used
ith non-diabetic patients.
rophylactic surgery to limit ulcer risk
n contrast, in case of sensorimotor lower limb neuropathy,
rthopedic surgery is high-risk and complications may lead
o the amputation meant to be prevented. Moreover, the
esultant trauma may induce neurogenic osteo-arthropathic
esions [47], although their frequency has not been deter-
ined. Onset of Charcot foot has also been described
ollowing revascularization surgery [48]. Given such Charcot
oot complications, which we have found following forefoot
urgery in diabetic subjects presenting with neuropathy, we
ow recommend ‘‘preventive’’ surgery to correct deformity
nly in case of history of ulcer facing bursitis and shoe-wear
onﬂict. Indications should be well thought out, cautious
nd justiﬁed. This surgery can only be performed as part
f a prospective study, with strict assessment of neuropathy
nd joint decision by a multidisciplinary team. Any history of
lcer increases the risk of infection (14% vs. 3—8%), although
mprovement in deformity is conserved over the long term
35].
Technically, in the forefoot, surgery consists in arthrode-
is rather than conservative procedures, especially in
orrecting hallux valgus, so as to avoid possible recurrence
equiring repeat surgery. Certain simple complementary
rocedures are available to prevent recurrence of forefoot
lcer: gastrocnemial lamina tenotomy (Strayer) or Achilles
engthening to reduce ﬁxed equinus, ﬂexor tenotomy for
educible claw toe, or interphalangeal arthroplastic resec-
ion [40]. Decompensation in abduction and medial Lisfranc
at foot may case mid-foot ulceration, and stabilization by
rthrodesis and plantar plate osteosynthesis can restore sta-
ility and avoid wound recurrence.
onclusion
iabetes is becoming pandemic. Diabetic foot lesions are a
ublic health issue of growing importance. Management can
nly be multidisciplinary.
The orthopedic surgeon plays a central role in providing
biomechanical perspective so as, following conservative
r surgical treatment, to avoid creating or leaving areas of
yperpressure that would induce recurrence of ulceration.
In case of ulceration, scheduled surgery is preferable
o emergency intervention, even in ‘‘acute’’ foot; lesions
hould always be cooled by antibiotherapy, even if this
as to be empiric. This enables more limited surgery, with
rst-intention suture to achieve rapid healing and shorter
ntibiotherapy courses.
Diabetic feet are high-risk neuropathic and vascular feet.
ascular assessment should always precede indication of
rthopedic surgery. If vascular status is insufﬁcient, prior
evascularization is mandatory.
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